Rafarma Pharmaceuticals Inc. (RAFA)

Overview

Rafarma Pharmaceuticals, Inc. is a diversified pharmaceutical company operating out of Sandy, Utah, with a significant presence in Russia, where its manufacturing and distribution facility is located. Initially known as Johnston Acquisition Corp., the company rebranded to Rafarma Pharmaceuticals, Inc. in October 2012. It specializes in the production and distribution of drugs, generic antibiotics, and specialty pharmaceuticals. With a broad range of products aimed at treating various medical conditions, Rafarma has established itself as a key player in the pharmaceutical industry. Additionally, the company has expanded its research and development efforts through a collaboration agreement with PlantEXT Ltd., focusing on the creation of medical cannabis suppositories for patients with inflammatory bowel disease. As of October 19, 2020, Rafarma Pharmaceuticals functions as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd., signaling a phase of growth and expansion into new territories and segments of the healthcare industry.

Products and Services

• Cephalosporin-Based Products - Rafarma offers a range of cephalosporin-based products, which are a class of antibiotics used to treat a wide variety of bacterial infections.
• Antibiotics of Non-ß Structure - The company provides antibiotics that do not belong to the ß-lactam class, designed for patients who might be allergic or resistant to standard antibiotics.
• Anti-Cancer Drugs - Rafarma produces anti-cancer drugs available in various forms including injections and ampulla-packaged products. These are aimed at treating different types of cancer with specialized medication formulations.
• Child Suspensions, Tablets, and Capsules - To accommodate the needs of pediatric patients, Rafarma develops and markets medications in child-friendly forms such as suspensions, tablets, and capsules.
• Medications for Accidental Wounds - The company offers a range of products designed to aid in the healing of accidental wounds, promoting faster recovery.
• Drugs for Inflammatory Eye Diseases - Rafarma provides treatments for various inflammatory eye conditions, helping to manage symptoms and improve patient quality of life.
• Immunological Disorder Drugs - There is a focus on developing drugs to treat a variety of immunological disorders, supporting the body’s immune system.
• Medical Cannabis Suppositories for Inflammatory Bowel Disease - In collaboration with PlantEXT Ltd., Rafarma is working on the research and manufacturing of medical cannabis suppositories. This innovative product is designed for patients suffering from inflammatory bowel disease, offering a novel approach to treatment.